Atara Biotherapeutics, Inc. (ATRA) Financials

ATRA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 188.8 million 239.6 million
2023-06-30 246.4 million 239.0 million
2023-03-31 302.1 million 237.1 million
2022-12-31 376.4 million 249.8 million

ATRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -51.6 million 11.1 million
2023-06-30 -53.3 million 12.6 million
2023-03-31 -38.8 million 11.8 million
2022-12-31 -56.9 million 11.4 million

ATRA Net Income

No data available :(

ATRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 102.4 million - 61.8 million
2023-06-30 153.6 million - 64.7 million
2023-03-31 205.4 million - 54.9 million
2022-12-31 242.8 million - 71.7 million

ATRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 106.4 million
2023-06-30 105.1 million
2023-03-31 104.0 million
2022-12-31 103.2 million

ATRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 281000 56.9 million 12.2 million -
2023-06-30 499000 56.1 million 13.3 million -
2023-03-31 399000 62.2 million 13.9 million -
2022-12-31 37000 62.5 million 13.2 million -

ATRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.1 million 2.6 million
2023-06-30 957000 2.9 million
2023-03-31 1.2 million 216000
2022-12-31 221000 4.1 million

ATRA

Price: $0.65

52 week price:
0.20
3.08

Earnings Per Share: -2.78 USD

P/E Ratio: -0.29

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 783100

Ebitda: -31.4 million

Market Capitalization: 73.1 million

Links: